| Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort VR Pimentel-Quiroz, MF Ugarte-Gil, GB Harvey, D Wojdyla, GJ Pons-Estel, ... Lupus 28 (9), 1101-1110, 2019 | 74 | 2019 |
| Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases JS Hausmann, K Kennedy, JF Simard, JW Liew, JA Sparks, TT Moni, ... The Lancet Rheumatology 3 (10), e707-e714, 2021 | 44 | 2021 |
| Abatacept for the treatment of systemic lupus erythematosus VR Pimentel-Quiroz, MF Ugarte-Gil, GS Alarcón Expert opinion on investigational drugs 25 (4), 493-499, 2016 | 42 | 2016 |
| LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo … MF Ugarte-Gil, RV Gamboa-Cardenas, C Reátegui-Sokolova, ... Lupus science & medicine 9 (1), e000616, 2022 | 21 | 2022 |
| Better health‐related quality of life in systemic lupus erythematosus predicted by low disease activity state/remission: data from the Peruvian Almenara Lupus Cohort MF Ugarte‐Gil, RV Gamboa‐Cárdenas, C Reátegui‐Sokolova, ... Arthritis Care & Research 72 (8), 1159-1162, 2020 | 21 | 2020 |
| Discrepant perception of lupus disease activity: a comparison between patients' and physicians' disease activity scores C Elera-Fitzcarrald, K Vega, RV Gamboa-Cárdenas, K Zúñiga, M Medina, ... JCR: Journal of Clinical Rheumatology 26 (7S), S165-S169, 2020 | 17 | 2020 |
| Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients C Reátegui-Sokolova, Z Rodríguez-Bellido, RV Gamboa-Cárdenas, ... Lupus 28 (11), 1344-1349, 2019 | 17 | 2019 |
| Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry SA Yeoh, M Gianfrancesco, S Lawson-Tovey, KL Hyrich, A Strangfeld, ... RMD open 8 (2), e002508, 2022 | 13 | 2022 |
| ANCA-associated vasculitis in Latin America: a systematic literature review: about their epidemiology and their clinical features VR Pimentel-Quiroz, SE Sattui, MF Ugarte-Gil, GS Alarcón JCR: Journal of Clinical Rheumatology 28 (1), 44-51, 2022 | 13 | 2022 |
| Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort MF Ugarte-Gil, RV Gamboa-Cardenas, C Reátegui-Sokolova, ... Lupus Science & Medicine 9 (1), e000641, 2022 | 12 | 2022 |
| Serum uric acid is associated with damage in patients with systemic lupus erythematosus C Elera-Fitzcarrald, C Reátegui-Sokolova, RV Gamboa-Cardenas, ... Lupus Science & Medicine 7 (1), e000366, 2020 | 12 | 2020 |
| Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort VR Pimentel-Quiroz, MF Ugarte-Gil, GJ Pons-Estel, ER Soriano, V Saurit, ... Seminars in arthritis and rheumatism 47 (2), 199-203, 2017 | 12 | 2017 |
| An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists AO Donskov, SL Mackie, EM Hauge, CE Toro-Gutiérrez, IT Hansen, ... Rheumatology 62 (8), 2797-2805, 2023 | 11 | 2023 |
| Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up RV Gamboa-Cárdenas, S Barzola-Cerrón, D Toledo-Neira, ... Clinical Rheumatology 40, 4725-4734, 2021 | 11 | 2021 |
| Demographic and clinical features of ANCA-associated vasculitides in a Peruvian tertiary center VR Pimentel-Quiroz, A Sánchez-Torres, E Acevedo-Vásquez, ... JCR: Journal of Clinical Rheumatology 27 (6S), S246-S251, 2021 | 11 | 2021 |
| Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica … KK Keller, CB Mukhtyar, AW Nielsen, AK Hemmig, SL Mackie, SE Sattui, ... Annals of the Rheumatic Diseases, 2023 | 10 | 2023 |
| Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort PA Zeña-Huancas, H Iparraguirre-López, RV Gamboa-Cárdenas, ... Clinical Rheumatology 38, 1139-1146, 2019 | 10 | 2019 |
| Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort MF Ugarte-Gil, RV Gamboa-Cardenas, C Reátegui-Sokolova, ... Lupus Science & Medicine 7 (1), e000419, 2020 | 9 | 2020 |
| Peripheral CD4+ CD28null T-cells as predictors of damage in systemic lupus erythematosus patients MF Ugarte-Gil, C Sánchez-Zúñiga, RV Gamboa-Cardenas, ... Clin Exp Rheumatol 36, 1008-13, 2018 | 8 | 2018 |
| The SLICC-FI predicts damage accrual in SLE patients. data from the almenara lupus cohort C Elera-Fitzcarrald, RV Gamboa-Cárdenas, C Reatégui-Sokolova, ... Lupus 31 (13), 1666-1670, 2022 | 7 | 2022 |
Manuel Francisco Ugarte-Gil, MD, MScUniversidad Científica del SurVerified email at cientifica.edu.pe
